Home Tools
Log in
Cart

Search Result

Search Results for " gepant "

10

Compounds

Cat No. Product Name Synonyms Targets
T8682 Vazegepant hydrochloride Vazegepant HCl CGRP Receptor
Vazegepant hydrochloride (Vazegepant HCl) is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
T4610 Rimegepant BMS 927711,BMS-927711,BMS927711,BHV-3000 CGRP Receptor
Rimegepant (BMS 927711) is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
T17194 Ubrogepant MK-1602 CGRP Receptor
Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in the acute treatment of migraine studies.
T12293L Olcegepant BIBN-4096,BIBN 4096BS CGRP Receptor
Olcegepant (BIBN-4096) is an effective and selective non-peptide calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (IC50 of 0.03 nM and Ki of 14.4 pM for human CGRP).
T73703 (3R,5R,6S)-Atogepant
Atogepant ((3R,5R,6S)-MK-8031) is the enantiomer of itself and serves as a calcitonin gene-related peptide (CGRP) receptor antagonist, primarily utilized in migraine research.
T38734 Vazegepant Zavegepant,BHV-3500
Vazegepant is an intranasal CGRP receptor antagonist utilized for conducting acute migraine research.
T26682 Atogepant MK 8031,MK8031. Atogepant,MK-8031
Atogepant is an antagonist of calcitonin gene-related peptide receptor.
T70837 Rimegepant sulfate hydrate
Rimegepant, also known as BMS-927711 and BHV-3000, is a potent, selective, competitive, and orally active calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraines. Rimegepant has shown ...
T16093 Telcagepant MK-0974 Others
Telcagepant is an orally active antagonist of calcitonin gene-related peptide (CGRP) receptor (Kis: 0.77 nM and 1.2 nM for human and rhesus CGRP receptors, respectively).
T12293 Olcegepant hydrochloride BIBN-4096 hydrochloride,BIBN4096BS hydrochloride Others
Olcegepant hydrochloride is a potent and selective non-peptidethe calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (with IC50 of 0.03 nM for human CGRP).
TargetMol